- Book
- March 2020
- 560 Pages
Global
- Book
- April 2024
- 1280 Pages
- Book
- April 2018
- 560 Pages
- Book
- July 2013
- 392 Pages
Global
- Book
- November 2011
- 496 Pages
Global
- Book
- April 2008
- 160 Pages
- Book
- September 2021
- 358 Pages
- Book
- February 2015
- 368 Pages
- Book
- November 2013
- 656 Pages
- Book
- January 2022
- 900 Pages

The Neuropathology market is a subset of the Neurosciences field that focuses on the diagnosis and treatment of diseases of the nervous system. It involves the study of the structure and function of the brain, spinal cord, and peripheral nerves, as well as the diagnosis and treatment of neurological disorders. Neuropathology is a rapidly growing field, with advances in technology and research leading to new treatments and therapies.
Neuropathology is a highly specialized field, requiring extensive training and experience. It is often used in conjunction with other medical disciplines, such as neurology, psychiatry, and neurosurgery. Neuropathologists are involved in the diagnosis and treatment of a wide range of neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and stroke.
Companies in the Neuropathology market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more